Skip to main content
Clinical Trials/TCTR20190829003
TCTR20190829003CompletedPhase 3

Intravenous plus intramyometrial oxytocin versus intravenous carbetocin during caesarean section in prevention of post-partum hemorrhage: a randomized controlled trial

Department of Medical Services0 sites50 target enrollmentStarted: August 29, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 55 Years (—)
Sex
Female

Inclusion Criteria

  • 1. Pregnant women undergo cesarean section with complete inform consent
  • 2. Age older than 18 years old
  • 3. Patient can able to fully understand Thai language
  • 4. No underlying hematologic disease

Exclusion Criteria

  • History drug (oxytocin or carbetocin) allergy
  • Placenta previa totalis
  • Abruptio placenta
  • Maternal illness (cardio,thyroid,preeclampsia, gestational diabetes,lung,liver,renal, anticoagulant)
  • Twin pregnancy
  • Classical uterine incision procedure
  • Fetal distress

Investigators

Similar Trials